Technical Analysis for LUMO - Lumos Pharma, Inc.

Grade Last Price % Change Price Change
F 2.64 -2.22% -0.06
LUMO closed down 2.22 percent on Monday, March 18, 2024, on 53 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Outside Day Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Jack-in-the-Box Bearish Bearish Swing Setup -2.22%
Calm After Storm Range Contraction -2.22%
Lower Bollinger Band Walk Weakness -2.22%
Inside Day Range Contraction -2.22%
Below Lower BB Weakness -2.22%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High about 10 hours ago
Up 5% about 10 hours ago
Up 3% about 10 hours ago
Up 2% about 11 hours ago
60 Minute Opening Range Breakout about 12 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Lumos Pharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for severe, rare, and genetic diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone stimulating small molecule, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency. The company has a licensing agreement with Ellipses Pharma Limited for the development of and rights to commercialize nanoparticle formulations of two therapeutics for oncology indications. Lumos Pharma, Inc. was founded in 2011 and is headquartered in Austin, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmacy Genetic Diseases Growth Hormone Growth Hormone Deficiency Growth Hormone Therapy

Is LUMO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.55
52 Week Low 2.5101
Average Volume 25,065
200-Day Moving Average 3.25
50-Day Moving Average 2.97
20-Day Moving Average 2.97
10-Day Moving Average 2.92
Average True Range 0.15
RSI (14) 31.03
ADX 22.17
+DI 10.75
-DI 29.78
Chandelier Exit (Long, 3 ATRs) 2.68
Chandelier Exit (Short, 3 ATRs) 2.96
Upper Bollinger Bands 3.23
Lower Bollinger Band 2.71
Percent B (%b) -0.13
BandWidth 17.67
MACD Line -0.06
MACD Signal Line -0.02
MACD Histogram -0.0449
Fundamentals Value
Market Cap 20.89 Million
Num Shares 7.91 Million
EPS -3.99
Price-to-Earnings (P/E) Ratio -0.66
Price-to-Sales 13.74
Price-to-Book 0.67
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.94
Resistance 3 (R3) 2.97 2.91 2.89
Resistance 2 (R2) 2.91 2.83 2.89 2.87
Resistance 1 (R1) 2.77 2.78 2.74 2.74 2.86
Pivot Point 2.71 2.71 2.69 2.69 2.71
Support 1 (S1) 2.57 2.63 2.54 2.54 2.42
Support 2 (S2) 2.51 2.58 2.49 2.41
Support 3 (S3) 2.37 2.51 2.39
Support 4 (S4) 2.34